Among the viruses circulating most are COVID-19, flu and RSV. So far this season, the CDC estimates, there have been at least 24 million flu illnesses, 310,000 hospitalizations and 13,000 deaths ...

Respiratory syncytial virus (RSV), or human respiratory syncytial virus (hRSV), is a common viral respiratory infection that triggers mild, cold-like symptoms. However, at-risk populations ...

But with COVID-19, the flu, respiratory syncytial virus, or RSV, and just the common cold all floating around and all sharing several similar symptoms, how are you supposed to know what you might ...

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study. The phase 3 randomized controlled ...

A nationwide surge in flu, COVID-19, RSV and norovirus infections is fueling concerns of a possible virus "quademic." Or is it just winter? The three respiratory viruses plus norovirus ...

Respiratory syncytial virus, known as RSV, is one of these alongside flu and coughs and colds. While most people are able to recover at home without seeking medical help the virus can be ...

Canada’s colder weather goes hand-in-hand with respiratory virus season, with flu, RSV and COVID-19 circulating. While Canadians learned a lot about how to protect themselves from illness during ...

MANILA, Philippines — Health professionals are working to raise awareness about Respiratory Syncytial Virus (RSV), a common contagious virus that usually causes mild to severe symptoms ...

Already competing to bring the first vaccine against respiratory syncytial virus (RSV) to market, Pfizer and GSK are also fighting a patent infringement battle in the courts. Earlier this month ...

Sanofi is trailing behind GSK and Pfizer when it comes to vaccines for respiratory syncytial virus (RSV), but it still thinks it can be the top player in the market with a combination of its ...